Advice for Physicians Entering the Field of Chronic Lymphocytic Leukemia

Bruce Cheson, MD


February 07, 2022

Bruce Cheson, MD, shares his enthusiasm about novel therapies in the management of chronic lymphocytic leukemia with practitioners who are entering the field. Dr Cheson looks beyond the available targeted therapies and stresses the importance of getting patients into clinical trials to develop novel strategies when patients do not respond to targeted therapies. He also looks to the future of CAR T-cell therapy and other immunotherapies in a "chemo-free world."


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.